Randomized controlled pilot trial of domperidone in relapsing remitting multiple sclerosis

被引：0
|
作者：
Liu, W. -Q. [1 ,2 ]
Zhornitsky, S. [1 ]
Greenfield, J. [1 ]
Pasha, R. [1 ]
Farah, G. Cerchiaro [1 ]
Zhang, Y. [3 ]
Pike, G. B. [3 ]
Yong, V. W. [1 ]
Metz, L. [1 ]
机构：
[1] Univ Calgary, Clin Neurosci, Calgary, AB, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Univ Calgary, Radiol & Clin Neurosci, Calgary, AB, Canada
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1208
引用
收藏
页码：633 / 633
页数：1
相关论文
共 50 条
  • [41] Effect of photobiomodulation on fatigue in individuals with relapsing–remitting multiple sclerosis: a pilot study
    Tamiris Silva
    Raquel Candido Alencar
    Bruna Cristina de Souza Silva
    Elaine Cristina Oliveira Martins Viana
    Yara Dadalti Fragoso
    Andréa Oliver Gomes
    Maria Cristina Chavantes
    Alessandro Melo Deana
    Juliana Maria Altavista Sagretti Gallo
    Kristianne Porta Santos Fernandes
    Raquel Agnelli Mesquita-Ferrari
    Sandra Kalil Bussadori
    [J]. Lasers in Medical Science, 2022, 37 : 3107 - 3113
  • [42] A pilot study of monocytes in relapsing remitting multiple sclerosis: Correlation with disease activity
    Taha, Sara, I
    Mohamed, Hala Ghareeb
    Mamdouh, Rasha
    Kamal, Nada E.
    Khater, Shaimaa Sayed
    [J]. INNATE IMMUNITY, 2024, 30 (05) : 90 - 95
  • [43] A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis
    Kaiser, Claudia C.
    Shukla, Dinesh K.
    Stebbins, Glenn T.
    Skias, Demetrios D.
    Jeffery, Douglas R.
    Stefoski, Dusan
    Katsamakis, George
    Feinstein, Douglas L.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 211 (1-2) : 124 - 130
  • [44] A pilot study to investigate structural vulnerability of hippocampus in relapsing remitting multiple sclerosis
    Zhao, L.
    Chen, Q.
    Au, C.
    Ng, A.
    Abrigo, J.
    Lau, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 478 - 479
  • [45] A PILOT TRIAL OF RECOMBINANT HUMAN INTERFERON-BETA IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS
    KNOBLER, RL
    GREENSTEIN, JI
    JOHNSON, KP
    LUBLIN, FD
    PANITCH, HS
    MARCUS, SG
    GRANT, SV
    DERYK, T
    LOMBARDI, J
    KATZ, E
    [J]. RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 121 - 124
  • [46] Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
    O'Connor, Paul
    Wolinsky, Jerry S.
    Confavreux, Christian
    Comi, Giancarlo
    Kappos, Ludwig
    Olsson, Tomas P.
    Benzerdjeb, Hadj
    Truffinet, Philippe
    Wang, Lin
    Miller, Aaron
    Freedman, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1293 - 1303
  • [47] B cell tailored ocrelizumab in relapsing multiple sclerosis: protocol of a randomized controlled trial
    Hogenboom, L.
    Mostert, J.
    Killestein, J.
    Van Kempen, Z.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 534 - 534
  • [48] Alemtuzumab for relapsing-remitting multiple sclerosis. Results of two randomized controlled phase III studies
    Klotz, L.
    Meuth, S. G.
    Kieseier, B.
    Wiendl, H.
    [J]. NERVENARZT, 2013, 84 (08): : 984 - +
  • [49] A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis
    Trojano, Maria
    Ramio-Torrenta, Lluis
    Grimaldi, Luigi M. E.
    Lubetzki, Catherine
    Schippling, Sven
    Evans, Karleyton C.
    Ren, Zheng
    Muralidharan, Kumar Kandadi
    Licata, Stephanie
    Gafson, Arie R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2240 - 2253
  • [50] A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
    Stein, M. S.
    Liu, Y.
    Gray, O. M.
    Baker, J. E.
    Kolbe, S. C.
    Ditchfield, M. R.
    Egan, G. F.
    Mitchell, P. J.
    Harrison, L. C.
    Butzkueven, H.
    Kilpatrick, T. J.
    [J]. NEUROLOGY, 2011, 77 (17) : 1611 - 1618
12345